What Are Biological Indicators?

Biological indicators were the foremost method of assessing the sterility of any medical or pharmaceutical environment through the use of some of the most resistant microorganism strains (eg. Bacillus or Geobacillus), rather than simply relying on meeting the requirements of both physical and chemical sterilization.  As the microorganisms used as biological indicators present in higher concentration […]

Global Exclusive License Signed

After nearly 18 months of development and negotiation, we are pleased to announce that Protak Scientific have been selected to be the global exclusive partner for Public Health England (PHE) (which is an executive agency of the Department of Health in the United Kingdom), for the commercialisation and development of thermostable Adenylate Kinase for verification […]

The Real Value Of Using Enzyme Indicators For Decontamination Validation

So where can the use of Enzyme Indicators for decontamination validation bring real value? Here we discuss some key areas where this new science will revolutionise current processes…   EI’s with pharmaceutical isolators or spaces that use VHP or HPV for decontamination EI’s start bringing value in the very early days for equipment manufacturers when […]

Compounded Sterile Drug Product Recalls Regarding Sterility and Quality Control

Compounded Sterile Drug Product Recalls Regarding Sterility and Quality Control – UPDATED April 2, 2015 FDA has alerted healthcare professionals and the public about multiple sterile compounding pharmacies having quality control and sterility issues. This alert does not include the New England Compounding Center information that was associated with fungal infections associated with their products. […]

Hospira Issues a Voluntary Recall Due to Mold Contamination

FDA PRESS RELEASE, FOR IMMEDIATE RELEASE — March 11, 2015 — LAKE FOREST, Ill. — Hospira, Inc. (NYSE: HSP), announced today it is initiating a voluntary recall of one lot of Lactated Ringer’s Irrigation, 3000mL (NDC 0409-7828-08, Lot 40-008-JT; Expiry 1APR2016) to the user level (both human and veterinary) due to a confirmed customer report […]

Heritage Initiates a Voluntary Recall Due to a Lack of Sterility Assurance

FDA PRESS, FOR IMMEDIATE RELEASE — February 24, 2015 — Eatontown, NJ, Heritage Pharmaceuticals Inc. (Heritage) today announced the voluntary nationwide recall of ten (10) lots of Colistimethate for Injection, USP, 150 mg Single-Dose vial (NDC 23155-193-31) and three (3) lots of Rifampin for Injection, USP, 600 mg Single-Dose vial (NDC 23155-340-31) manufactured by Emcure […]

FDA alert – Voluntary Recall – Potential Impact on Product Sterility

ISSUE: Sagent Pharmaceuticals, Inc. announced the voluntary nationwide recall of two lots of Atracurium Besylate Injection, USP, 50mg/5mL single-dose vials (NDC 25021-659-05) and four lots of Atracurium Besylate Injection, USP, 100mg/10mL multi-dose vials (NDC 25021-672-10) manufactured by Emcure Pharmaceuticals Ltd. and distributed by Sagent. Sagent has initiated this voluntary recall of Atracurium Besylate Injection, USP, […]

Potential contamination with Bacillus cereus

ITH Pharma Ltd is recalling specific batches of Lipid Phase Parenteral Nutrition from specific hospitals. This is because of a potential contamination with Bacillus cereus identified following a small number of reported cases of Bacillus cereus septicaemia affecting neonates. All batches have expired and it is believed that there is little or no stock remaining […]